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ABSTRACT 
Milk is the sole food for breast-fed infants and a significant source of nutrition for consumers 
of dairy products. It has a very complex composition containing both macronutrients and 
micronutrients needed for growth and development. Drugs, carcinogens and environmental 
toxins can be secreted in milk posing a potential health risk for breast-fed infants and milk 
consumers. Active transport by membrane proteins in secretory mammary epithelial cells can 
explain this process. Several membrane protein transporters from different protein families 
(Solute carrier (SLC) and ATP-binding cassette (ABC) super families) mediate transport of a 
wide range of different compounds. 
The major purpose of this project was to investigate transporter protein expression of mouse 
Bcrp, Mdr1, Octn1 and Oatp3 (Oatp1a5) by using a murine mammary epithelial HC11 cell 
line. Differentiated HC11 cells featuring a milk protein synthesizing and secreting phenotype 
were used in western blot experiments to detect the proteins of interest. In this cell model it 
was possible to detect upregulation of membrane transporters mouse Bcrp and Octn1 as a 
result of the differentiation. In addition, immunohistochemistry on lactating mouse mammary 
gland tissues was performed to detect the localization of mouse Octn1. Octn1 was localized at 
the apical membrane of mammary epithelial cells supporting the theory that it plays a role in 
the transport of carnitine into milk. The impact of lipopolysaccharide (LPS) treatment, 
mimicking mammary inflammation, on protein expression of transporters in secreting HC11 
cells were examined by western blotting. However, at the LPS concentration used no effects 
were detected.  
This study provides basic tools for understanding the nature of secretion of nutrients and 
nonnutrients to milk by membrane transporters. Further investigations are required to 
understand the correlation between protein expression and function of membrane transporters 
in secreting HC11 cells.  
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1. INTRODUCTION 
1.1 Milk is a nutrient source and a source of contaminants for the newborn 
Milk is the sole food for breast-fed infants and a significant source of nutrition in consumers 
of dairy products. It has very complex composition containing both macronutrients and 
micronutrients needed for growth and development. It is a nutrient source of proteins, lipids, 
vitamins, amino acids, minerals as well as hormones, growth factors and enzymes (Haug et 
al., 2007). In addition to this unique advantage of breast milk; drugs, carcinogens and 
environmental toxins also can be secreted in milk (Jonker et al., 2005). When at high milk-to-
serum (M/S) ratio is observed in animal experiments studies especially for drugs, their 
accumulation into milk may involve active transport by transporter proteins (Alcorn et al., 
2002). Thus, contamination of milk with such xenobiotics and drugs poses a potential health 
risk for breast-fed infants and dairy consumers. 
1.2 Mammary gland development in mouse during puberty, pregnancy, lactation and 
involution 
Embryonic development of mammary gland starts to appear by day 12. Because of the fast 
proliferation of epithelial cells mammary epithelium gains a new shape by day 14 and 
continues by day 16 forming mammary sprout. This sprout grows into ductal tree which 
consists of several branching ducts until birth (Richert et al., 2000). Hormones are 
continuously involved in all stages of mammary gland development (Meyer et al., 2004). 
Estrogen and growth hormones are responsible for the ductal morphogenesis (Neville et al., 
2002). Postnatal development occurs after embryonic development has ended and consists of 
two parts. In puberty ductal growth has roles in lengthening and branching of the epithelium. 
Alveolar differentiation appears during pregnancy and alveolar buds become responsible units 
for the milk secretion (Richert et al., 2000). The proliferative phase of alveolar morphogenesis 
needs prolactin and progesterone hormones to be able to start differentiation (Neville et al., 
2002).  
Lobular alveolar structures grow during pregnancy and the mammary gland is converted to 
exocrine organ from a simple ductal tree. This process creates a lot of changes including 
hormonal changes in the cellular composition of the mammary gland. To be able to achieve 
successful transport and secretory functions, some biochemical properties also change during 
pregnancy (Meyer et al., 2004). Lobuloalveolar phase of the mammary growth takes place at 
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the beginning of the pregnancy when the alveolar buds start to divide and differentiate into 
individual alveoli which are responsible for milk secretion during lactation. To produce milk, 
the alveoli expand through the fat pad and the lumen is filled by milk containing milk proteins 
and lipids. When lactation starts, the mammary gland is totally filled by alveoli. Lactation 
continues for about 3 weeks in mice when the pups are weaned (Richert et al., 2000). 
Following weaning milk synthesis in the mammary epithelial cells stops and involution and 
remodeling of mammary tissue takes place.  At the end of the involution the mammary gland 
is observed as a prepregnant resting gland (Meyer et al., 2004). 
1.3 Hormone dependent proliferation and differentiation stages of HC11 cells 
HC11 mammary epithelial cells can be used as a model for investigating cellular 
differentiation which is regulated by hormones (Desrivières et al., 2007). Since this epithelial 
cell line preserves the characteristics of normal mammary epithelial stem cells, it is still being 
used as a well-established in vitro system in studies related with gene and protein expression 
(Desrivières et al., 2007). Under the control of lactogenic hormones this cell line is able to 
synthesize the major mouse milk protein beta casein (Doppler et al., 1989). The origin of the 
cell line was emerged from mid-pregnant BALB/c mouse mammary gland tissue (Danielson 
et al., 1984). This regulatory function of the hormones shows synergistic effect to induce 
differentiation from a proliferative to differentiated stage (Desrivières et al., 2007). Janus 
kinase (Jak) - signal transducer and activator of transcription (Stat) pathway (Jak/Stat 
pathway) is activated by prolactin thereby inducing differentiation of the cells (Pauloin et al., 
2012). Stat 5 is a signaling factor for transcription which takes place in protein- protein 
interactions with glucocorticoids and mediates the prolactin response (Reichardt et al., 2001). 
Transcription of the beta-casein which is the marker of mammary gland differentiation is 
activated by the glucocorticoids action by the physical interaction between its receptor and 
Stat5 (Desrivières et al., 2007). The growth of the epithelial cells until they become confluent 
occurs in the presence of insulin and epidermal growth factor (EGF) but glucocorticoids start 
the differentiation working together with insulin and prolactin (Shan et al., 2008). The 
synthesis of milk proteins including caseins, whey acidic protein and α-lactalbumin is induced 
by prolactin in synergy with glucocorticoids (Pauloin et al., 2012). It has been shown that 
estrogens are needed for the development of ductal system after birth while progesterone is 
needed during pregnancy for the lengthening and branching of ducts and for the growth of 
lobuloalveolar system (Reichardt et al., 2001).  
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1.4 Transport mechanisms in mammary gland 
There are a lot of activities taking place in mammary gland including passive diffusion and 
active transports of various substances. There are five major pathways for both transport of 
substances and secretion of milk protein, lipids, nutrients and ions into milk. The exocytotic 
pathway stands for the milk protein secretion and also for oligosaccharides and various 
nutrients that are packaged into secretory vesicles and transported to the apical region of the 
cells. When these vesicles leave the Golgi and reach to the apical plasma membrane, they 
complete their function by merging the content into the extracellular space. Lipid secretion 
pathway is unique to mammary epithelial cells and basically lipids and lipid- associated 
proteins are transported to the apical plasma membrane as membrane enveloped structures 
called milk fat globules. Transcytotic pathways work on transport of the macromolecules 
starting from the basal membrane to the apical membrane. Immunoglobulin A and prolactin 
can be given as example substances for this type of transport. Membrane transport pathway 
contains lots of different mechanisms for ions, glucose and amino acids. The movement of 
these substances from blood to the milk is a kind of transcellular transfer and to be able to 
complete the transport; specific transporters are needed at the basal and apical plasma 
membranes which have roles in active transport in alveolar cells. Unlike passive diffusion 
active transport is not dependent on concentration gradient. It is believed that active transport 
mechanisms took place when certain drugs’ concentrations are present in milk higher than 
expected. Passive diffusion can be predicted by physical characteristics of the compounds 
while active transport cannot. The paracellular transport is responsible for the transport of 
substances that have low molecular weight and also for the macromolecules. But mammary 
epithelial cells have tight-junctions between each other except during pregnancy, involution 
and in inflammatory states as mastitis. These tight junctions are responsible to control 
paracellular exchange of any kind of substances (McManaman et al., 2003). 
1.5 ATP- binding cassette transporters 
The ABC transporter superfamily members are known as responsible transporters by an 
energy dependent manner and they are believed to efflux molecules in the presence of ATP 
binding or hydrolysis (Robey et al., 2011). Some recent and interesting studies have been 
done with these transporters on contamination of milk with drugs, pesticides and other 
xenotoxins (Jonker et al., 2005). Two important efflux membrane proteins are heavily 
involved in transport of these exogenous compounds: ABCB1/P-glycoprotein (P-gp)/MDR1 
and ABCG2/breast cancer resistance protein (BCRP) (Krishnamurthy et al., 2006). The breast 
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cancer resistant protein BCRP is encoded by the ABCG2 gene and the multidrug resistance 
protein (P-gp) is encoded by the ABCB1 (or MDR-1) (van Herwaarden et al., 2006b) 
1.5.1 Breast cancer resistance protein (Bcrp/Abcg2) 
BCRP was first cloned from a MCF7 multidrug-resistant breast cancer cell line and its name 
comes from there (Staud et al., 2005). By radiation hybrid analysis, Allikmets et al. (1998) 
mapped the ABCG2 gene to human chromosome 4q22, between markers D4S2462 and 
D4S1557. The mouse Bcrp1 is very similar to human BCRP. Because of that reason 
numerous functional BCRP experiments have been performed in mice (van Herwaarden et al., 
2006a). BCRP has a 72-kDa molecular weight with 665 amino acids and it has ATP- binding 
domain at N-terminal as well as six transmembrane domains (TMD) at the C-terminal which 
are responsible for drug binding and efflux of the substrates (Staud et al., 2005). Substrates 
cross membranes by using ATP and this is provided by nucleotid binding domain (NBD) and 
it is believed that these domains are highly conserved (Krishnamurthy et al., 2006). 
Localization of the BCRP has been shown several times in different studies by 
immunohistochemical detection and concluded to be at the apical side in most of the 
mammalian tissues such as epithelium of the intestine, kidney, placenta, and the bile 
canalicular membrane and also in mammary gland (Staud et al., 2005 and Jonker et al., 2005). 
While BCRP has a protective function in most of tissues in the body by controlling 
disposition of the substrates and protecting body by pumping xenobiotics out, in the 
mammary gland this protective function turns out a harmful function. Since it is upregulated 
in the lactating mammary gland of mice and humans, it can transport high amounts of BCRP 
substrates like PhIP (2-amino-1-methyl-6-phenylimidazo [4, 5-b] pyridine) from mother into 
the milk (Robey et al., 2011). The upregulation of Bcrp at the protein level has also been 
shown in mouse mammary gland epithelium during late pregnancy by western blot analysis 
(Jonker et al., 2005). 
1.5.2 Multidrug resistance protein 1 (Mdr1/P-gp) 
Another important member of the ATP-binding cassette (ABC) superfamily that has been 
studied extensively is P-glycoproteins (Schinkel et al., 1997). The gene coding for P-gp in 
humans was first isolated and cloned in the 1980s. The protein has 170-kDa molecular weight 
and the protein structure is like many other ABC proteins (Leonessa et al., 2003). It has two 
membrane binding domains that contain six transmembrane (TM) helices for each and two 
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cytoplasmic nucleotide-binding (NB) domains which have roles in binding and hydrolyzing 
ATP (Jones et al., 2004). Some studies have showed that Pgp protein is present and expressed 
at low levels in most tissues but it is mostly localized at the apical surface of the epithelial 
cells in liver, colon, kidney and pancreatic ductules (Thiebaut et al., 1987). Because of its 
localization in many tissues it is believed that Pgp plays a role in the protection of the organs 
by secreting of metabolites and xenobiotics out of the epithelial cells (Schinkel et al., 1997). 
Beside these tissues, some studies at RNA level of transporter genes in the lactating mammary 
epithelial cells has showed that MDR1 is expressed in mammary epithelial cells and unlike 
BCRP, it is down regulated in lactating mammary epithelial cells during lactation (Alcorn et 
al., 2002). The down regulation of Mdr1 at the protein level has also been shown in mouse 
mammary gland epithelium during late pregnancy by western blot analysis (Jonker et al., 
2005). 
1.6 Organic cation transporters (Solute carrier transporters)  
The mammary gland is known as milk-producing organ but it is not the only useful 
characteristic of it. It mediates a stabilized transfer of compounds by increasing nutrients and 
endogenous bioactive factor accumulation in milk and by restricting transfer of toxic 
substances and nonnutritional compounds. It was believed that this transfer was caused by ion 
trapping or passive diffusion. Although the molecular mechanisms are not fully understood, 
some studies have shown accumulation or excretion of these organic cations in milk are 
higher than expected from passive diffusion and ion trapping (Kwok et al., 2006)  
There are a lot of studies of membrane transporters belonging to the organic cation 
transporters (OCT) family in various tissues and also in different species which have been 
shown that this transporter family has important roles in the absorption, distribution and 
elimination of various cationic drugs, xenobiotics and endogenous metabolites or zwitterions 
(Lahjouji et al., 2001) These proteins are classified as the solute linked carrier family (SLC).  
SLC are responsible for the transfer of specific compounds into epithelial cells across the 
apical membrane. These transporters have wide substrate specificity (Sugiura et al., 2010). L-
carnitine is the most important and essential substrate for solute carrier transporters that have 
been investigated in many studies and the relationship between them is still being 
investigated. L-carnitine is a small water-soluble zwitterion, have critical physiological roles 
as a cofactor that involves in the β-oxidation of long chain fatty acids and glucose oxidation in 
the muscle and heart for ATP generation. Carnitine generates energy for brain in the 
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development of the nervous system. Because of its function in many different tissues but 
especially in early brain growth and development, carnitine delivery via breast milk to the 
newborn can be considered a major issue during lactation. (Lamhonwah et al., 2011) 
It has been shown that carnitine is transported by a family of three carnitine/organic cation 
transporters; Organic Cation Transporter, Novel Protein, Type1 (OCTN1), Type 2 (OCTN2) 
and Type 3 (OCTN3) (Lamhonwah et al., 2011). It was first cloned from human fetal kidney 
(Tamai et al., 1997) and is expressed in different tissues in mouse such as intestine, liver 
(Sugiura et al., 2010) and mammary gland (Kwok et al., 2006). Mouse Octn1 has 553 amino 
acids and it works as a Na+ -dependent carnitine transporter. The comparison by Alcorn et al., 
(2002) of RNA expression levels of transporters in lactating and nonlactating mammary 
epithelial cells has shown that the gene expression of human OCTN1 upregulated during 
lactation. 
1.7 Organic anion transporters (Solute carrier transporters) 
Membrane solute carriers are responsible for mediating the sodium independent transport. It 
occurs in bidirectional manner by receiving some organic compounds into cells and pumping 
bicarbonate and glutathion out of the cells. These transporters are expressed in different 
tissues such as choroid plexus, blood brain barrier (BBB), lung, heart, intestine, placenta, 
testis, kidney and testis. Organic Anion Transporting Polypeptides (Oatp/OATPs) are a group 
of this transporter family and have very extensive range of amphipathic organic substrates 
including bile salts, thyroid hormones, organic dyes, anionic oligopeptides, different drugs 
and xenobiotic compounds. There was already one old and traditional classification for this 
family but since this classification system doesn’t give accurate and species independent 
identification, researchers have created a new species-independent classification and 
nomenclature system which was divided into families, subfamilies, individual genes and gene 
products based on the similar amino acid sequence identities ( Hagenbuch et al., 2004) 
Solute carrier organic anion transporter family member 1A2 (OATP1A2) [previously called 
anion transporting polypeptide A (OATP-A)/ (SLC21A3)] was the first human superfamily 
member and it was isolated by hybridization screening from human liver. OATP1A2 has four 
homologs within the subfamily OATP1A and the one that we are interested in is solute carrier 
organic anion transporter family member 1A5 (Oatp1a5) [previously called Organic Anion 
Transporting Polypeptide 3 (Oatp3)/ (Slc21a7) (Hagenbuchet al., 2003). Radiation hybrid 
analysis has demonstrated the human OATP-A gene has been localized on chromosome 12 
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and it was shown that OATP-A is the human ortholog of mouse Oatp3 (Oatp1a5) by 
fluorescent in situ hybridization studies (Walters et al., 2000). Generally the molecular weight 
for the Oatps/OATPs protein family can differ between 60 and 90 kDa. Basically they all 
have 12 transmembrane domains with C terminal and N terminal that are localized at the 
intracellular side (Hagenbuchet al., 2003). Although some Oatps/OATPs are selectively 
expressed (only in a single tissue), many of them show multiple tissue expression. Based on 
its function on the tissue Oatps can be localized at the basolateral side of the cell as well as at 
the apical side (Hagenbuchet al., 2004). Hagenbuchet al., (2004) has shown that some Oatps 
appears to be expressed in different sides of the epithelial cells in different organs in rat while 
Oatp3 (Oatp1a5) shows consistent apical expression in polar epithelial cells. The comparison 
of RNA expression levels of each transporter in lactating and nonlactating mammary 
epithelial cells have been shown by Alcorn et al., (2002) and according to this research the 
gene expression of OATPA which is the homologous gene of Oatp3 is upregulated during 
lactation (Hagenbuchet al., 2003). 
1.8 Simulation of bovine mastitis using HC11 cells and lipopolysaccharides (LPS) 
Mastitis stands for inflammatory reaction of the udder tissue in bovine mammary gland. 
When the pathogens invade teat canal of the mammary gland, the number of the white blood 
cells (leucocytes) increases to prevent damage caused by inflammation. 137 different 
organisms were identified as a cause of mastitis including bacteria, mycoplasma, yeast and 
algae. Since most of the mastitis pathogens are bacterial origin, Staphylococcus aureus and 
Escherichia coli seemed to be major bacterial pathogens which are responsible for bovine 
mastitis (Bradley et al., 2002). Little information is available about impacts of subclinical 
mastitis on active transport of chemicals into milk. Lipopolysaccharide (LPS) is an endotoxin 
found in the outer membrane of Gram-negative bacteria, such as S. aureus and E.coli. It 
would be interesting to examine the effect of LPS on protein expression of transporters in 
secreting HC11 cells. There are some studies related with Octn1 regarding the effects of 
inflammation on L-carnitine transporter expression in the mammary gland. It is believed that 
transporter expression and function might change during differentiation and it may depend on 
different lactation stages in the mammary gland. Ling et al., (2010) has showed the 
upregulated expression levels without statistical significance of L-carnitine transporter Octn1 
in the mammary gland tissue when the lactating rats were treated with lipopolysaccharide 
(LPS) at different lactation stages. 
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2. AIMS OF THE STUDY 
The major purpose of this project was to investigate transporter protein expression of mouse 
Bcrp, Mdr1, Octn1 and Oatp3 (Oatp1a5) by using a murine mammary epithelial HC11cell 
line. To be able to use this cell line, the differentiation of the HC11 cells into a milk protein 
synthesizing and secreting phenotype need to be achieved. Western blotting techniques were 
performed to detect the proteins of interest. In addition, immunohistochemistry on lactating 
mouse mammary gland tissues was performed to detect the localization of mouse Octn1. 
Second aim was to examine impact of lipopolysaccharide (LPS) inflammation on protein 
expression of transporters in secreting HC11 cells. 
3. MATERIALS AND METHODS 
3.1 HC11 cell culturing 
Murine mammary epithelial cell line HC11 was used for the determination of transporter 
proteins’ expression levels. The cells were grown in sterile filtered RPMI 1640 medium 
supplemented with 2mM L-Glutamine, 25 mM HEPES (Gibco, Invitrogen, Carlsbad USA), 
gentamicin 50 μl/ml (Gibco, Invitrogen, Carlsbad USA), 7.5 % sodium bicarbonate, bovine 
insulin 5 mg/l (Sigma-Aldrich, St Louis, USA), EGF (epidermal growth factor)-5μg/l and 
10% heat-inactivated foetal bovine serum (FBS) (Gibco, Invitrogen, Carlsbad USA) at a pH 
between 7.3 and 7.4. The culture was grown at 37°C in 5% CO2. Culture medium was 
changed every 2-3 days. 
When the cells had reached 80-90% confluence, they were passaged: 
The culture medium was aspirated from the flask and the cells were washed in sterile 
phosphate buffered saline (PBS) solution (15ml/75cm
2
 or 5ml/25cm
2
). PBS was removed and 
3ml/75cm
2
 or 1ml/25cm
2
 Cell Dissociation Solution (Gibco, Invitrogen, and Carlsbad, CA, 
USA) was added and followed by incubation for 10-20 minutes at 37°C in 5% CO2. When the 
cells were detached, they were suspended with 12ml/75cm
2
 or 4ml/25cm
2
 of culture medium, 
transferred to a falcon tube and spinned down at 450xG for 5 minutes at 4°C in a GS-GR 
centrifuge (Beckman Coulter, Fullerton, USA). The supernatant was removed carefully and 
the cell pellet was resuspended in a suitable amount of medium by pipetting up and down for 
several times. The cell suspension was transferred into new flasks prefilled with warmed 
growth medium.  
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Differentiating Cells (Protocol I) 
Cells were cultured in growth medium for 3-4 days post confluency. After this, cells were 
stimulated to differentiate by exchanging growth medium with differentiating medium 
(growth medium – EGF, -FBS, + prolactin (Sigma-Aldrich, St Louis, USA) 1 μg/ml, +cortisol 
(Sigma-Aldrich, St Louis, USA) 1μM). The cells were grown in differentiating medium for 3-
4 days in 25cm
2
/75cm
2
 flasks. Two/three bottles of differentiated cells were grown in 
differentiated medium and two/three bottles of undifferentiated cells were grown in regular 
growth medium, as controls. 
 
Differentiating Cells (Protocol II) 
The HC11 cells were cultured in growth medium for 6 days post confluency. After this cells 
were washed with PBS and maintained in growth medium without EGF for 24 hours. To 
induce lactogenic differentiation the cells were incubated in differentiation medium for 3-4 
days as described above.  
3.2 Treatment of HC11 cells with Lipopolysaccharide (LPS) 
The differentiation medium was aspirated from differentiated cells and the cells were washed 
with DMEM (15ml/75cm
2
). To induce experimental inflammation cells were incubated at 
37°C in 5% CO2 in the presence of 10μg LPS/ml for 2 days. Control cells were incubated in 
LPS-free medium. LPS treatment was used to mimic mastitis in HC11 cells. 
3.3 Lactate Dehydrogenase (LDH) cell toxicity test to LPS treated differentiated HC11 
cells 
1 ml of the medium was taken from both the lipopolysaccharide treated cell culture and the 
non-treated control cell culture just prior to protein isolation (as described below). 4.65 ml 
Tris HCl buffer (0.2mM pH 7.3) and 175μl of the NADH stock solution (6.6 mM) were 
mixed and vortexed shortly. 195μl of this diluted NADH solution was added into each well in 
a 96-well plate. 10 μl duplicate samples from the cell toxicity test per well were used. Two 
different control samples were used including low LDH and high LDH samples from previous 
experiments and the microplate was covered with parafilm, incubated at room temperature for 
15-20 minutes. Then microplate was put in a microplate reader and incubated at 25°C for 
another 5 minutes. After incubation 15μl of the Na-pyruvate solution (30mM)/well was added 
by using a multichannel pipette without taking the microplate out. Absorbance values 340nm 
14 
 
were recorded (6 times for each well) and LDH concentrations calculated by applying the 
following formula: 
LDH (U/ml) = ∆A340nm per min/ (0.001 x 0.1 x lightpath (cm))    
3.4 Isolation of proteins using RIPA-Buffer 
The culture medium was aspirated and the cells were washed in sterile phosphate buffered 
saline (PBS) solution (15ml/75cm
2
 or 5ml/25cm
2
). PBS was removed. The cells were 
detached from the flasks by treatment with 1.5ml of trypsin and the flasks were inverted 
gently to assure that trypsin has reached to all cells. Trypsin was aspirated and the cells were 
incubated for 5 minutes at 37°C in 5% CO2. Trypsin was neutralized by addition of 10 ml of 
basal medium containing 10% FBS. Cells were suspended; they were transferred to a falcon 
tube and spinned down at 450xG for 5 minutes at 4°C in a GS-GR centrifuge (Beckman 
Coulter, Fullerton, USA). The supernatant was removed carefully and the cell pellet was 
solved in 250/500μl RIPA buffer (Radio Immuno Precipitation Assay buffer- containing 47.5 
ml 1X TE buffer (10 mM Tris-HCl, pH 8; 1 mM EDTA), 0.4383 g NaCl, 0.5 g NP-40 
(nonylfenoxy-polyetoxy-ethanol; Tergitol) 0.5 ml 10% SDS (sodium dodecyl sulphate), 0.5 
tablet Complete protease inhibitor cocktail (Roche), 1X TE buffer up to 50 ml). The cell 
suspension was pipetted up and down repeatedly until a homogenate solution was obtained. 
Mammary tissues were obtained from previous experiments with lactating mice approved by 
the Local Ethics Committee of Animal Research (permit no. C159/2). Tissues were 
homogenized with the suitable amount of RIPA buffer (0.1μg/μl) by using plastic 
homogenizer.  
The homogenates were transferred into new eppendorf tubes and were then incubated on ice 
for 30 min followed by centrifugation for 30 min at 16000 x g. Supernatants were transferred 
carefully to new eppendorf tubes without touching the cell pellet. The isolated proteins were 
stored at -70 °C for further application 
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3.5 Determination of protein concentration 
 
BCA assay was performed and bovine serum albumin (BSA) was used as protein standard. 
Dilutions for standard protein (concentration of BSA was 2mg/ml and the final volume was 
250ul): 
Table 1 Concentration of Standards for BSA assay 
BSA (mg/ml) BSA (μl) RIPA Buffer (μl) 
0 0 250 
0,025 3,125 246,875 
0,05 6,25 243,75 
0,1 12,5 237,5 
0,3 37,5 212,5 
0,5 62,5 187,5 
0,7 87,5 162,5 
1 125 125 
 
The first 3 columns in 96-well plate were used for the standard calibration curve. It was done 
in triplicates according to the above table. The next columns were used for unknown samples, 
triplicates for control samples and triplicates for differentiated samples. BCA Protein Assay 
Reagents were prepared by mixing 0.2 ml coppersulphate (reagent B) and 9.8 ml BCA 
(reagent A). A green solution formed. 190 μl of this mixture and 10 μl of each sample were 
added to each well. The well plate was covered with parafilm and incubated at 37°C for 30 
minutes in the incubator oven. The absorbance was measured at 570nm by applying a 
microplate reader. Amount of protein in each well was calculated by plotting a standard curve 
on Excel. The protein concentrations were determined based on the equation for each of the 
unknown samples and their concentration units were the same as standard.    
3.6 Gel electrophoresis 
 Sodium Dodecyl Sulfate PolyAcrylamide Gels (SDS-PAGE) were used to separate proteins 
according to their molecular weight. The protein expression of mouse Bcrp, Mdr1, Oatp3 
(Oatp1a5) and Octn1 was examined in the control and differentiated cells of HC11 cell line 
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and also in mammary gland tissues from non-lactating virgin and lactating day 7 mouse as 
positive controls. In all experiments two control samples (control 9 and control 10) and two 
differentiated samples (differentiated 9 and differentiated 10) were used originating from 
different T75 flasks but grown at the same time. Western blotting with the samples from LPS 
treatment was done by using the same protein extraction. Protein samples were prepared 
boiling 5 minutes at 95°C in laemmli buffer with 1:1 raito with samples (Laemmli buffer was 
prepared with 950μl of laemmli and 50μl of betamercaptoethanol). BioRad Mini-PROTEAN 
Ready Gels (10%, 10-well comb, 50μl wells) was placed into the electrophoresis tank. The 
tank was filled with SDS-PAGE running buffer (10x Tris/Glycine/SDS buffer). Samples were 
loaded into each well using a long thin pipette tip. 7.5μl loading standard was added as 
molecular weight markers and 15-40 μl (20-50μg of protein) of each sample was loaded onto 
the gel. The tank was closed with the lid and electrodes were connected to the power supply. 
The gel was run at 30mA at room temperature until the loading dye had reached to the bottom 
of the gel. The gel was removed from the plastic covers and incubated in transfer buffer 
(Methanol and Tris glycine buffer) for 20 min. The gel was used for western blotting or 
Coomassie blue staining. 
Coomassie blue staining 
SDS-PAGE gel was removed from plastic plates and rinsed in milliQ water in a suitable 
container. Coomassie stain was added enough to cover the gel and it was incubated for 1 hour 
on the shaker. Then Coomassie Stain was poured off and the gel was rinsed twice with water 
to remove Coomassie Stain from the container. Destain solution was added enough to cover 
the gel and it was renewed every 30 minutes until the proteins bands became visible. An 
imaging system the Bio-Rad Molecular Imager ChemiDoc XRS was used for documentation 
of the gel. The Figure 1 shows the separation of the proteins. 
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Figure 1 HC11 cell proteins from control samples and proteins from mouse virgin and lactating day 7 were separated on 
SDS-PAGE gel and visualized with Coomassie Staining. 
3.7 Protein transfer to nitrocellulose membrane 
The proteins were separated by SDS-electrophoresis and the SDS-PAGE gel was transferred 
to nitrocellulose membrane (0.45 um pore) by electrophoretic transfer by using the BioRad 
Mini Trans-Blot Electrophoresis Transfer Cell. All the materials in the blocking sandwich 
were incubated in transfer buffer which consisting of sponge, filter paper, SDS-PAGE gel, 
nitrocellulose membrane, filter paper and sponge. They were placed in the transfer cassette 
with the gel on the side of negative electrode (black) and the membrane on the side of the 
positive electrode. Protein transfer was performed at 350 mA for 1.25 hour. During the 
blotting procedure an ice bar was out in the buffer tank and the whole tank was placed in a 
box full of ice to keep the temperature of the transfer buffer below 40°C  
3.8 Detection of proteins on a Western Blot by Chemiluminescent Detection Kit 
After the transfer of proteins from gel to a nitrocellulose membrane, the membrane was 
incubated in 50 ml of blocking buffer (5% nonfat dry milk powder in Tris based saline 
containing 0.05% Tween 20) over night at 4°C cold room on a shaker to block non-specific 
binding sites. The next day the membrane was washed three times (15 min each) with  25 ml 
of TBS-T (For 1L TBS-T 8 g NaCl, 0.2 g KCl and 3 g of Tris base mixed and dissolve in 800 
ml of milliQ water. pH was adjusted to 7.5, the volume was brought to 1L and 0.05% Tween 
20 added) and then incubated with primary antibody (1:100-200 dilutions in 15 ml in blocking 
buffer) for one hour at room temperature under gentle shaking. The membrane was washed 
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three times with 25 ml of TBS-T buffer for 15 min each and incubated for one hour at room 
temperature with HRP-conjugated secondary antibody solution (1:7500 dilutions in 15 ml of 
blocking buffer) under gentle shaking covered with aluminum foil to avoid light. The 
membrane was then washed three times with 15 ml of TBS-T for 15 min each and finally 
incubated for 5-7 min in 1:1 mixture of luminol/enhancer and peroxide buffer (Immun-Star 
WesternC Chemiluminescent- BioRad or ECL Select Western Blotting Detection Reagent-GE 
Healthcare). 5 ml total solution (2.5 ml of luminol/enhancer and 2.5 ml of peroxide solution) 
was sufficient for one membrane. The developing solution was removed and the membrane 
was placed into a plastic wrap to prevent drying. An imaging system the Bio-Rad Molecular 
Imager ChemiDoc XRS was used to measure the intensities of obtained bands by applying 
Quantity One software. Tubulin was used as a loading control to make a comparison between 
the expressions of a protein in different samples (Fig.2, Fig.3, Fig.4, and Fig.5). Tubulin 
normalization was performed to be able to compare the expression levels (Fig.6 and Fig.7). 
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3.9 Western blots; primary and secondary antibodies 
3.9.1 Primary antibodies 
Table 2 Primary antibodies that have been used for both Western Blot and Immunohistochemical analyses 
Protein MW Species 
Conc. 
Dilution 
Type Source 
BCRP/ABCG
2 
[BXP-53] 
73.03 kDa 
Reacts with an 
internal epitope of 
BCRP/ABCG2 in 
mouse and human 
1:100 
0.25mg/
ml 
Rat 
monoclonal 
Abcam 
Pgp (JSB-1 
Antibody) 
170.00 kDa 
Anti-P-glycoprotein 
Mouse 
1:200 
1ml 
Rat 
monoclonal 
Abcam 
Oatp3(Oatp1a
5) (N-19):sc-
47266 
74.67 kDa 
Epitope mapping 
near the N-terminus 
of Oatp3 of mouse 
origin 
1:500 
200µg/ml 
Goat 
polyclonal 
IgG 
Santa 
Cruz 
Biotechn
ology 
Octn1 (P-12): 
sc-19820 
64.00 kDa 
Epitope mapping 
within an internal 
region of OCTN1 of 
mouse origin 
1:200 
200µg/ml 
Goat 
polyclonal 
IgG 
Santa 
Cruz 
Biotechn
ology 
Anti-Tubulin 
antibody 
[YOL1/34] 
50.00 kDa 
Reacts with mouse, 
rat, dog and human 
1:3000 
100µg 
(1mg/ml) 
Rat 
monoclonal 
Abcam 
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3.9.2 Secondary antibodies 
Table 3 Secondary antibodies that have been used for both Western Blot and Immunohistochemical analyses 
Name Conc. Dilution Source 
Donkey anti-goat IgG-HRP: sc-
2020 
1:7500 
200 µg/0.5 ml 
Santa Cruz Biotechnology 
Rabbit Polyclonal Secondary 
Antibody to Mouse IgG-H&L 
(HRP) (ab6728) 
1:7500 
2 mg/ml 
Abcam 
Rabbit Polyclonal Secondary 
Antibody to Rat IgG-H&L 
(HRP)(ab6734) (Tubulin)  
1:5000 Abcam 
Polyclonal Goat Anti Mouse 
Immunoglobulins/Biotinylated 
(E0433) 
1:200 Dako Cytomation 
 
3.10 Stripping of nitrocellulose membranes  
Stripping buffer contained 62.5 mM Tris-HCl, 100 mM 2-mercaptoethanol and 2% SDS was 
prepared to remove primary and secondary antibodies bound to a western blot membrane. All 
membranes were incubated 30 minutes at 60°C with 15 ml of stripping buffer on shaker. The 
membrane was washed three times with 25 ml of TBS-T buffer for 15 min each and incubated 
with suitable primary and secondary antibodies (for Tubulin primary antibody 1:3000 
dilutions in 15 ml in blocking buffer and for Tubulin secondary antibody 1:7500 dilutions in 
15 ml of blocking buffer were used). 
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3.11 Immunohistochemical detection of mouse Octn1 
The lactating mouse mammary gland tissue was fixed for about 24 hours in 10% formalin to 
preserve the tissue. It was cut in suitable size and is placed in plastic cassettes. The plastic 
cassettes with the tissue were placed in a dehydration machine (histokinett). Tissue was 
dehydrated in alcohol from 70% to 100% and was treated in xylene and finally it was 
infiltrated in paraffin. The tissue was imbedded in paraffin in suitable forms to make a 
paraffin block. The paraffin block with the tissue was sectioned on a microtome in about 3 to 
5 microns thin sections. They were placed on a glass slide and dried on a heating plate for 
about 1-2 hours. 
The primary goat polyclonal antibody used for staining of Octn1 was prepared 1:50, 1:200, 
and 1:500 dilutions. The tissues were hydrated by a graded alcohol series starting with X-
TRA Solv, 96% alcohol and continue with 70% alcohol. Antigen retrieval was performed 
with Tris/EDTA buffer containing 10mM Tris Base, 1mM EDTA solution and 0.05% Tween 
20 at pH 9.0 at 98°C for 20 minutes. Then the tissues were blocked in two steps. First one was 
done by incubation in 1% hydrogen peroxide followed by a brief wash in PBS. 10% normal 
goat serum was then used for the second blocking step. The slides were incubated with the 
diluted primary antibody over night at 4°C and they were washed two times with PBS. 1:200 
diluted secondary polyclonal goat anti mouse antibody was added for 30 minutes at room 
temperature. The tissues were washed with PBS several times and incubated with AB 
complex (Vestastain ABC kit) solution for 30 min derived from Vector lab which was 
prepared for half an hour before usage. Sections were washed again with PBS two times for 5 
minutes for each followed by the addition of the DAB (3, 3’-diaminobenzidine) substrate 
solution and the reaction was stopped by immersing the slides in water. Sections were counter 
stained for 20 seconds in Mayers hematoxylin. The slides were washed and the tissues were 
dehydrated. After this the cover slips were mounted with X-TRA Kitt mounting medium and 
dried overnight.  
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4. RESULTS 
4.1 BCA assay for determination of protein concentration by two different cell culture 
protocols 
Two different cell culture protocols were used to induce differentiation using the same 
chemicals in HC11 cell line. As demonstrated in Table 4 a much higher protein concentration 
was achieved when we used second cell culture protocol. The result of the protein 
concentration from second protocol was almost 10 times higher than protein concentration 
from the first cell culture protocol in control HC11 cells. Protein concentration of 
differentiated HC11 cells was almost 40 times higher when in the second cell culture protocol. 
Table 4 The protein concentration in HC11 cells from two cell culture protocols  
Passage number 31 
First Cell Culture 
Protocol Protein 
Concentration 
(mg/ml) 
Passage number 32 
Second Cell 
Culture Protocol 
Protein 
Concentration 
(mg/ml) 
Control 1 0,61 Control 9 6,52 
Control 2 0,67 Control 10 6,73 
Differentiated 1 0,08 Differentiated 9 4,59 
Differentiated 2 0,11 Differentiated 10 4,71 
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4.2 Western Blot analyses of transporter proteins expressed in HC11 cells 
Protein expression of breast cancer resistance protein Bcrp/Abcg2 in HC11 cells and 
mouse mammary gland   
Using Bcrp transporter specific antibodies applied to HC11 cells and mouse mammary gland 
the bands on 72 kDa corresponding to the predicted molecular weight of Bcrp were detected 
in Western Blots of HC11 cell line and positive control tissue samples. There was a 
remarkable upregulation of Bcrp in the mammary gland at lactating day 7 mouse compared to 
the virgin mice. Expression of Bcrp in HC11 cells looked similar based on Western Blot 
membrane images (Fig.2). As shown in fig. 6a based on protein/tubulin ratios Bcrp protein 
expression was almost two times higher in differentiated HC11 cells than in undifferentiated 
cells. This data agrees with the results shown in fig.7a that demonstrate an almost 15 times 
higher expression of Bcrp in mammary gland of lactating mouse than the virgin.  
 
Figure 2 Protein expression of Bcrp/Abcg2 in the mammary gland. (a) Western blots on undifferentiated and differentiated 
HC11 cells (50μg per lane) with Bcrp antibodies and loading control tubulin. Two different controls (control 9 and control 
10) and two different differentiated samples (differentiated 9 and differentiated 10). (b) Western blots of tissue samples from 
virgin and lactating day 7 female mouse mammary gland and loading control tubulin. 
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Protein expression of multidrug resistance protein Mdr1/Pgp in HC11 cells and mouse 
mammary gland   
 Transporter specific primary antibodies and corresponding secondary antibodies were applied 
to HC11 cells and mouse mammary gland epithelial cells. The detected bands were more 
closed to the molecular weight 250 kDa (Fig.3) in both in vitro and in vivo situations and it 
was hard to distinguish downregulation or upregulation on the blots without quantification 
analyses. After tubulin normalization Mdr1 tended to be somewhat downregulated in 
differentiated HC11 cells (Figure 6b). In lactating mouse mammary gland we found an 
increasing protein expression (Figure 7b). 
 
Figure 3 Protein expression of Mdr1/P-gp in the mammary gland. (a) Western blots on undifferentiated and differentiated 
HC11 cells (50μg per lane) with Mdr1antibodies and loading control tubulin. Two different controls (control 9 and control 
10) and two different differentiated samples (differentiated 9 and differentiated 10). (b) Western blots of tissue samples from 
virgin and lactating day 7 female mouse mammary gland and loading control tubulin. 
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Protein expression of Oatp3 (Oatp1a5) in HC11 cells and mouse mammary gland 
The protein expression of Oatp3 was examined using an antibody against N-terminus of 
Oatp3 of mouse origin in HC11 cells and also in mouse mammary gland epithelial cells. The 
immunoreactivity was detected in both HC11 cells and mouse mammary gland tissues at 75 
kDa which indicates that the antibody reacts with mouse Oatp3 as expected (Fig.4a, 4b). 
Since the bands were weaker than expected, the comparison of the protein expressions 
between different samples has been done after tubulin normalization as shown in Figure 6 and 
Figure 7. The protein expression of this transporter was similar in both undifferentiated and 
differentiated HC11 cells as well as in tissue samples. 
 
Figure 4 Protein expression of Oatp3 (Oatp1a5) in the mammary gland. (a) Western blots on undifferentiated and 
differentiated HC11 cells (50μg per lane) with Oatp3 antibodies and loading control tubulin. Two different controls (control 9 
and control 10) and two different differentiated samples (differentiated 9 and differentiated 10). (b) Western blots of tissue 
samples from virgin and lactating day 7 female mouse mammary gland and loading control tubulin. 
 
 
 
 
 
 
 
 
 
26 
 
Protein expression of Octn1 in HC11 cells and mouse mammary gland   
The protein expression of Octn1 was examined using an antibody against the internal region 
of Octn1 of mouse origin in HC11 cells and also in mouse mammary gland epithelial cells. 
The bands were detected between 50 and 75 kDa since the predicted molecular weight of 
Octn1 is 64 kDa. The background was totally clear and only these bands appeared on the blot 
which indicates that the antibody specifically reacts with mouse Ocnt1 as expected (Fig. 5a, 
5b). The comparison of the protein expressions between different samples has been done after 
tubulin normalization as shown in Figure 6 and Figure 7. Octn1 was upregulated in 
differentiated HC11 cells and also in mammary tissue from lactating mouse. 
 
Figure 5 Protein expression of Octn1 in the mammary gland. (a) Western blots on undifferentiated and differentiated HC11 
cells (50μg per lane) with Octn1 antibodies and loading control tubulin. Two different controls (control 9 and control 10) and 
two different differentiated samples (differentiated 9 and differentiated 10). (b) Western blots of tissue samples from virgin 
and lactating day 7 female mouse mammary gland and loading control tubulin. 
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For analyzing Bcrp, Mdr1, Oatp3 and Octn1 protein expressions in HC11 cells, experiments 
were repeated several times and the protein/tubulin ratios were calculated by taking average. 
Normalized expression levels of the transporters are illustrated in Figure 6. 
 
Figure 6 Quantification analyses of transporter proteins in HC11 cells by protein/tubulin ratio. Results from cells grown in 
individual culture flasks are shown. Two different controls (C9 and C10) and two different differentiated samples (D 9 and 
D10).  
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For analyzing Bcrp, Mdr1, Oatp3 and Octn1 protein expressions in tissue samples, 
experiments were repeated several times and the protein/tubulin ratios were calculated by 
taking average. Normalized expression levels of the transporters are illustrated in Figure 7. 
 
 
Figure 7 Quantification analyses of transporter proteins in mammary gland tissues by protein/tubulin ratio. Results from 
tissues obtained from individual mice are shown. Tissue samples from virgin and at lactating day 7 female mice mammary 
gland (LD7).  
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4.3 Western Blot analysis of LPS treatment 
Protein expression of Bcrp, Mdr1, Oatp3 (Oatp1a5) and Octn1 in LPS treated HC11 cells 
The protein expression of Bcrp, Mdr1, Oatp3 (Oatp1a5) and Octn1 was examined using 
specific antibodies to mouse origin to see if there is any differences at the protein expression 
levels when the differentiated HC11 cells were treated with lipopolysaccharides. The bands 
were detected at the predicted molecular weight for all transporter proteins (Fig.8). The 
comparison of the protein expression levels between different samples has been done after 
tubulin normalization as shown in Figure 9. We found similar values in both nontreated 
(NLPS) and treated (LPS) HC11 cells for all transporters (Figure 9). 
 
Figure 8 Protein expressions of Bcrp, Mdr1, Oatp3 and Octn1 in the LPS treated and non-treated (NLPS) HC11 cells (50μg 
per lane). (a) Western blots of mouse Bcrp on the LPS and NLPS treated HC11 cells and loading control tubulin.  (b) 
Western blots of mouse Mdr1 on the LPS and NLPS treated HC11 cells and loading control tubulin. (c) Western blots of 
mouse Oatp3 (Oatp1a5) on the LPS and NLPS treated HC11 cells and loading control tubulin. (d) Western blots of mouse 
Octn1 on the LPS and NLPS treated HC11 cells and loading control tubulin. 
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For analyzing Bcrp, Mdr1, Oatp3 and Octn1 protein expression in LPS treated and untreated 
HC11 cell line, experiments were repeated several times only for some of the transporters 
because of the limited time and the protein/tubulin ratios were calculated by taking average to 
compare expression levels between different samples (Fig.9) 
Figure 9 Quantification analyses of transporter proteins in LPS treated and non-treated (NLPS) HC11 cells by protein/tubulin 
ratio. Results from all secreting cells grown in individual culture flasks are shown. 
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4.4 LDH cell toxicity test 
When the cells are treated by lipopolysaccharide (LPS) at cytotoxic levels, the enzyme lactate 
dehydrogenase (LDH) which is normally present in the cells will be released out of the cells 
in to the medium where the cells are growing. The concentration of LDH in the medium 
indicates the toxicity and the degree of damage of the cells. LDH toxicity test was performed 
to examine if there is any damage in the differentiated cells when they were treated with LPS. 
In this assay cell culture medium was used both from LPS treated and untreated cells. Two 
different positive controls were used containing low and high LDH, respectively to be able to 
analyze the cell damage. Duplicate samples were used for each sample and the mean value 
presented. Although it is unknown why untreated cell culture medium gave more LDH 
concentration than LPS treated cell culture medium, they were still lower than the sample 
which contains low LDH (Fig.10). 
 
Figure 10 Results from cells grown in individual culture flasks are shown. LDH concentrations in one LPS treated cell 
culture medium and one non-treated (NLPS) cell culture medium. Two positive controls contain low and high LDH.  
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4.5 Immunohistochemical localization of Octn1 in lactating mammary glands of mice 
Localization of mouse Octn1 in lactating mammary glands of mice was performed. The 
results showed that Octn1 protein is predominantly localized to the apical membranes of the 
mammary epithelial cells, whereas negligible staining was observed in myoepithelial and 
ductal cells (Figure 11 A). No staining was observed when primary antibodies were omitted 
and replaced by mouse specific IgG as negative control (Figure 11 B). 
 
Figure 11 A localization of organic cation transporter Octn1 in lactating mammary gland epithelial cells of mouse by 
immunostaining (1000X magnification) on the upper two images. The mammary gland tissues were prepared as described in 
MATERIALS AND METHODS and 1:500 dilutions of the primary antibody are presented. The area that demonstrates the 
localization of Octn1was cropped and presented below these two figures. Arrows indicate localization of Octn1 protein as 
brown staining. B demonstrates a negative control of the epithelial cells stained with only negative control mouse IgG. 
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5. DISCUSSION  
The biggest achievement of this study was to optimize protocols for Western Blotting of 
transporter proteins isolated from murine HC11 mammary epithelial cells. The optimal 
protocol was developed and used to investigate protein expression of transporters in secreting 
mammary epithelial cells. Since this method contains many steps, we have faced a lot of 
problems such as high background, no signaling, multiple bands, white spots or black dots on 
the blot etc. until the protocol was optimized. Although most of the problems seemed to be 
solved and the method is a promising tool, it still needs to be repeated to obtain best results.  
Transporter proteins are involved in active transport of different exogenous compounds and 
substances into milk. In the present study we have examined protein expression of mouse 
Bcrp, Mdr1, Oatp3 (Oatp1a5) and Octn1 in HC11 cells. As a quality control protein 
expression of the transporters was also analyzed in mouse mammary tissue from a virgin 
mouse and from a mouse on lactation day 7. The undifferentiated control cells were used as 
model of non-secreting mammary gland epithelial cells while the differentiated cells were 
used as model to mammary gland epithelial cells of lactating mouse. As shown in Figure 2 the 
expected band size 72 kDa was achieved in the presence of 50 µg proteins for mouse Bcrp in 
both HC11 cells and tissue samples. Bcrp expression in mammary glands of lactating and 
nonlactating mouse correlated with the results reported by Jonker et al., 2005 in mouse. In the 
present study Bcrp expression was high and seemed to be upregulated in the mammary gland 
of lactating mouse as well as in the differentiated HC11 cells (Figure 6a and Figure 7a). As 
shown in the fig. 6a based on protein/tubulin ratios Bcrp protein expression was almost two 
times higher in differentiated HC11 cells than undifferentiated cells. This data agrees with the 
results shown in fig.7a that represent almost 15 times higher expression in mammary gland of 
lactating mouse than the virgin.  
We have shown that mouse Mdr1 is expressed both in HC11 cells and mammary gland tissue 
samples. Mdr1 has high molecular weight with 170 kDa and the detected bands of interest 
were more closed to the higher molecular weight 250 kDa on the blot (Figure 3). Since this 
protein is quite big, the separation of the proteins might not be efficient due to the relatively 
high gel percentage or it may need to be incubated more than 5 minutes at 95°C to assure all 
the disulfide bonds were cleaved. We have also detected multiple bands for tissue samples 
from virgin and lactating day 7 mouse mammary glands. Also some novel proteins or 
different splice variants that share similar epitopes and could be possibly from the same 
protein family might have been detected. Tubulin detection on the predicted size was efficient 
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even though it was weaker for tissue samples than the detected bands for HC11 cells (Figure 
3b). After tubulin normalization Mdr1 tended to be somewhat downregulated in HC11 cells 
(Figure 6b) in differentiated cells. Furthermore, although it has been shown by Jonker et al., 
2005 that Mdr1 was downregulated during lactation in mouse with a very strong decreased 
protein expression, we have demonstrated totally opposite results with an increasing protein 
expression in lactating mouse mammary gland (Figure 7b). According to these preliminary 
results, the experiment should be repeated. 
Mouse Oatp3 (Oatp1a5) protein expression was detected in both HC11 cells and tissue 
samples demonstrating that the specific antibodies reacted with mouse Oatp3 at the predicted 
molecular weight 75kDa as expected (Figure 4a and 4b). After tubulin normalization the data 
gave similar values in both undifferentiated and differentiated HC11 cells as well as in tissue 
samples. Upregulation of OATPA (ortholog of mouse Oatp3) at gene level has been reported 
by Alcorn et al., (2002) in lactating human mammary epithelial cells. But in the present study 
there were no effects of mouse Oatp3 neither in HC11 cells nor mouse mammary gland tissue 
samples (Figure 6c and Figure 7c).  
As shown in Figure 5a, b expected bands were detected between 50 and 75 kDa for Octn1. 
Although the estimated size of Octn1 is ~ 64kDa, the detected bands were consistently closer 
to 50 kDa in several trials, suggesting post transcriptional modifications or degradation. 
Octn1/Tubulin ratio data showed that the organic cation transporter Octn1 was upregulated in 
differentiated HC11 cells and also in tissue samples from lactating mouse (Figure 6d and 
Figure 7d). 
Our present study showed expression and localization of Octn1 by immunohistochemistry 
staining using polyclonal goat antibody against mouse Octn1. Staining seemed to be very 
specific as shown in Fig. 11A since the dilution factor of antibody was high (1:500). Method 
should be optimized to improve these preliminary results by decreasing the dilution factors or 
trying different blocking kits. Octn1 is predominantly located at the apical membrane of 
lactating mouse mammary epithelial cells. It sounds logical when we think about carnitine 
delivery to the new born through breast milk suggesting that Octn1 can be an efflux 
transporter since carnitine has to be transported actively into the milk to improve early brain 
growth and development of the newborn.    
Another aim of this project was to investigate impacts of lipopolysaccharide (LPS) 
inflammation on protein expression of transporters in secreting HC11 cells. The 
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immunoreactive bands for four different transporters were detected on the estimated sizes on 
western blots (Figure 8). It is believed that inflammation can alter the expression of 
membrane transporters at both gene and protein levels. It has been reported by Ling et al., 
(2010) that mRNA expression levels of glucose, fatty acid and carnitine transporters in whole 
mammary tissue treated with LPS are dependent on different lactation stages and these 
authors demonstrated that LPS administration markedly increased Octn1 expression. The 
expression alterations by inflammation in both gene and protein levels have also been 
reported for one of the ABC family efflux transporters Mdr1 by Al-bataineh et al., (2010). 
According to RT-PCR and Western Blot analyses they demonstrated a significant increase in 
the gene and protein expression levels of Mdr1 after inflammation. However, in the present 
study we found similar values in both nontreated (NLPS) and treated (LPS) HC11 cells for all 
transporters (Figure 9). When the LDH cell toxicity test was performed to detect membrane 
damage and asses cell toxicity, it was also concluded that the used concentration of LPS was 
not toxic. It might be argued that the absence of effects could be due to a too low 
concentration of LPS. It could also be different sensitivity in different cell lines and by 
different inducers of inflammation.  
HC11 in vitro cell model was used in all these experiments. Two different cell differentiation 
protocols were used to optimize the experimental conditions. In this study we were able to 
achieve a much higher protein concentration when we used second cell culture protocol. As 
presented in Table 4, when the second culture protocol was performed on HC11 cell 
differentiation, the result of the protein concentration was almost five times higher than the 
first cell culture protocol protein concentration. Although different incubation times was 
performed in these two protocol to induce differentiation, the difference of protein 
concentrations was probably caused by some steps during protein extraction including 
detachment methods, using lower volumes of lysis buffer or using different size of cell culture 
flasks.  
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6. CONCLUSION  
In this cell model it was possible to detect upregulation of membrane transporters mouse Bcrp 
and Octn1 at differentiation stage. Based on the observed results, further investigations on 
membrane transporters expressed in the mammary gland and the active secterion of nutrients 
into the milk by these transporters are definitely needed. Octn1 was localized at the apical 
membrane of mammary epithelial cells which is in line with its role in the transport of 
carnitine into milk. More studies are required to understand the possible role of Octn1 in 
transporting xenobiotics in the mammary epithelium. No effect was detected by LPS on 
protein expression of transporters in secreting mammary epithelial cells possibly because of a 
too low LPS concentration. The latter findings should be clarified by exposing the cells for 
various LPS concentrations and/or longer periods to elucidate effects of inflammation on gene 
and protein expression.  
 
7. ACKNOWLEDGEMENTS 
I would like to thank my two supervisors Agneta Oskarsson and Jonas Tallkvist for their 
continuous guidance, assistance and support. I would also like to thank Agneta Boström for 
valuable help with the immunohistochemistry studies as well as all people at Department of 
Biomedical Sciences and Veterinary Public Health, Division of Pathology, Pharmacology and 
Toxicology, Swedish University of Agricultural Sciences. 
 
 
 
 
 
 
37 
 
8. REFERENCES 
Al-Bataineh, M.M., van der Merwe, D., Schultz, B.D., Gehring, R. (2010). Tumor Necrosis 
Factor Alpha Increases P-glycoprotein Expression in a BME-UV In Vitro of Mammary 
Epitheliak Cells. Biopharm. Drug Dispos. 31: 506-515 
 
Alcorn, J., Lu, X., Moscow, J.A., Mcnamara. P.J. (2002). Transporter Gene Expression in 
Lactating and Nonlactating Human Mammary Epithelial Cells Using Real-Time Reverse 
Transcription-Polymerase Chain Reaction. The Journal of the Pharmacology and 
Experimental Therapeutics 303:487-496 
 
Burgoyne, R.D., Duncan, J.S. (1998). Secretion of Milk Proteins. Journal of Mammary Gland 
and Neoplasia, Vol. 3, No. 3. 
 
Bradley, A.J. (2002). Bovine Mastitis: An Evolving Disease. The Veterinary Journal, 163, 1-
13. 
 
Danielson K. G., Oborn C. J., Durban E. M., Butel J. S., and Medina D. 1984. Epithelial 
mouse mammary cell line exhibiting normal morphogenesis in vivo and functional 
differentiation in vitro. Proc Natl Acad Sci USA. 81, 3756–3760.  
 
Desrivières S, Prinz T, Castro-Palomino Laria N, Meyer M, Boehm G, Bauer U, Schäfer J, 
Neumann T, Shemanko C, Groner B. (2003). Comparative proteomic analysis of 
proliferating and functionally differentiated mammary epithelial cells. Mol Cell Proteomics, 
2, 1039-54. 
 
Doppler W, Groner B, Ball RK. (1989). Prolactin and glucocorticoid hormones synergistically 
induce expression of transfected rat _-casein gene promoter constructs in mammary epithelial 
cell line. Proc Natl Acad Sci, 86, 104-8. 
 
Groner, B. (2002). Transcription factor regulation in mammary epithelial cells. Domestic 
Animal Endocrinology 23, 25-32 
 
Hagenbuch, B., Meier, P.J. (2004). Organic anion transporting plypeptides of the 
OATP/SLC21 family: phylogenetic classification as OATP/SLCO superfamily, new 
nomenclature and molecular/functional properties. Pflugers Arch-Eur J Physiol 447: 653-665 
 
Hagenbuch, B., Meier, P.J. (2003). The superfamily of organic anion transporting 
polypeptides. Biochimica et Biophysica Acta 1609, 1-18 
 
Haug, A., A. T. Hostmark, and O. M. Harstad. 2007. Bovine milk in human nutrition--a 
review. Lipids Health Dis 6: 25.  
 
38 
 
Jones PM, George AM 2004. The ABC transporter structure and mechanism: perspectives on 
recent research. Cell Mol Life Sci 61:682-699 
 
Jonker, J.W., Merino, G., Musters, S., van Herwaarden, A.E., Bolscher, E., Wagenaar, E., 
Mesman, E., Dale, T.C., Schinkel, A.H. (2005). The Breast cancer resistance protein BCRP 
(ABCG2) concentrates drugs and carcinogenic xenotoxins into milk. Nature Medicine, 
 
Krishnamurthy, P.,  Schuetz,  J.D. (2006) Role of ABCG2/BCRP in Biology and Medicine. 
Annu. Rev. Pharmacol. Toxicol. 46:381–410 
Kwok, B., Yamauchi, A., Rajesan, R., Chan, L., Dhillon, U., Gao, W., Xu, H., Wang, B., 
Takahashi, S., Semple, J., Tamai, I., Nezu, J.I., Tsuji, A., Harper, P., Ito, S. (2006). 
Carnitine/zenobiotics transporters in the human mammary gland epitjelia, MCF12A. Am J 
Physiol Regul Integr Comp Physiol 290: R793-R802 
 
Lahjouji, K., Mitchell, G.A., Qureshi, I.A. (2001). Carnitine Transport by Organic Cation 
Transporters and Systemic Carnitine Deficiency. Molecular Genetixs and Metabolism 73, 
287-297 
 
Lamhonwah, A.M., Mai, L., Chung, C., Lamhonwah, D., Ackerley, C., Tein, I. (2011). 
Upregulation of mammary gland OCTNs maintains carnitine homeostasis in suckling infants. 
Biochemcal and Biophysical Research Communications 404, 1010-1015. 
 
Lamote I, Meyer E, Massart-Leën AM, Burvenich C.  (2004).  Sex steroids and growth 
factors in the regulation of mammary gland proliferation, differentiation, and involution.  
Steroids, 69, 145-59 
 
Leonessa, F., Clarke, R. (2003). ATP binding cassette transporters and drug resistance in 
breast cancer. Endocrine-Related Cancer, 10, 43-73 
 
Ling, B., Alcorn, J. (2010). LPS-induced inflammation downregulates mammary gland 
glucose, fatty acid, and L-carnitine transporter expression at different lactation stages. 
Research in Veterinary Science 89, 200-202. 
 
McManaman JL, Neville MC. (2003). Mammary physiology and milk secretion. Adv Drug 
Deliv Rev, 55, 629-41. 
 
Neville MC, McFadden TB, Forsyth I. (2002). Hormonal regulation of mammary 
differentiation and milk secretion. J Mammary Gland Biol Neoplasia, 7, 49-66. 
 
Pauloin, A., Chanat, E. (2012). Prolactin and epidermal growth factor stimulate adipophilin 
synyhesis in HC11 mouse mammary epithelial cells via the PI3-kinase/Akt/mTOR pathway. 
Biochimica et Biophysica Acta 10,4C 
 
39 
 
Reichardt, H.M., Horsch, K., Gröne, H.J., Kolbus, A., Beug, H., Hynes, N., Schütz, G. 
(2001). Mammary gland development and lactation are controlled by different glucocorticoid 
receptor activities. European Journal of Endocrinology 145, 519-527. 
 
Richert MM, Schwertfeger KL, , Ryder JW, Anderson SM. (2000). An atlas of mouse 
mammary gland development. J Mammary Gland Biol Neoplasia 5, 227-41. 
 
Robey, R.W., To, K.K.K, Polgar, O., Dohse, M., Fetsch, M.D., Bates, S.E. (2011). ABCG2: 
A perspective. Adv Drug Deliv Rev.  
 
Sakakura, T., Kusano, I., Kusakabe, M., Inaguma, Y., Nishizuka, Y. (1987). Biology of 
mammary fat pad in fetal mouse: capacity to support development of various fetal epithelia in 
vivo. Development. 100, 421-430 
 
Schinkel, A.H. (1997). The physiological function of drug-transporting P-glycoproteins. 
Cancer Biology, Vol 8: pp 161-170 
 
Shan, L., Zhang, R., Zhang, W., Lee, E., Sridhar, R., Snyderwine, E.G., Wang, P.C. (2008).        
Image-based evaluation of the molecular events underlying HC11 mammary epithelial cell 
differentiation. Analytical Biochemistry. 382, 122-128  
 
Staud, F., Pavek, P. (2004), Breast cancer resistance protein (BCRP/ABCG2). Int J Biochem 
Cell Biol, 37, 720-5. 
 
Sugiura, T., Kato, S., Shimizu, T., Wakayama, T., Nakamichi, N., Kubo, Y., Iwata, D., 
Suzuki, K., Soga, T., Asano, M., Iseki, S., Tamai, I., Tsuji, A., Kato, Y. (2010). Functional 
Expression of Carnitine/Organic Transporter OCTN1/SLC22A4 in Mouse Small Intestine and 
Liver. The American Society for Pharmacology and Experimental Therapeutics 38: 1665-
1672. 
 
Tamai, I., Yabuuchi, H., Nezu, J., Sai, Y., Oku, A., Shimane, M., Tsuji, A. (1997). Cloning 
and characterization of a novel human pH-değendent organic cation transporter, OCTN1. 
FEBS Letters 419, 107-111. 
 
Thiebaut, F., Tsuruo, T., Hamada, H., Gottesman, M.M., Pastan, I., Willingham, M.C. (1987). 
Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal 
human tissues. Proc. Natl. Acad. Sci. USA Vol. 84, pp. 7735-7738 
 
Van Herwaarden, A.E., Wagenaar, E., Merino, G., Jonker, J.W., Rosing, H., Beijnen, J.H., 
Schinkel, A.H. (2006a). Breast cancer resistance protein (BCRP/ABCG2) secretes riboflavin 
(vitamin B2) into milk. Molecular and Cellular Biology p. 1247–1253 
40 
 
Van Herwaarden, A.E., Schinkel, A.H. (2006b). The function of breast cancer resistance 
protein in epithelial barriers, stem cells and milk secretion of drugs and zenotoxins. TRENDS 
in Pharmacological Sciences Vol 27.No.1 
Walters, H.C., Craddock, A.L., Fusegawa, H., Willingham, M.C., Dawson, P.A. (2000). 
Expression, transport properties, and chromosomal location of organic anion transporter 
subtype 3. Am J Physiol Gastrointest Liver Physiol 279: G1188-G1200. 
